Neurologic Imaging

Why Is Imaging Usually Not Appropriate for Bilateral Tinnitus with a Normal Exam?

·
Why Is Imaging Usually Not Appropriate for Bilateral Tinnitus with a Normal Exam?

A 58-year-old patient reports a persistent, high-pitched ringing in both ears for the past six months. It’s a constant, non-pulsing sound. The otoscopic and neurologic examinations are entirely normal, and the patient denies any hearing loss, vertigo, or recent trauma. Your initial thought might be to order an MRI of the head to look for a cause, a common reflex when faced with a vexing neurologic symptom. However, for this specific clinical scenario—bilateral, nonpulsatile tinnitus with a normal exam—the American College of Radiology (ACR) Appropriateness Criteria take a firm stance. For nearly all imaging modalities, including advanced studies like MRI and CT, the rating is Usually not appropriate. This article details the evidence-based rationale for withholding imaging in this low-risk population and outlines the appropriate clinical workflow.

Who Fits This Clinical Scenario?

This guidance applies to a very specific and common patient population: adults presenting with bilateral, nonpulsatile tinnitus as their primary complaint. The key inclusion criteria for this conservative, non-imaging pathway are:

  • Bilateral Symptoms: The tinnitus is perceived in both ears.
  • Nonpulsatile Character: The sound is a steady tone (e.g., ringing, hissing, buzzing) and does not pulse in sync with the patient’s heartbeat.
  • No Hearing Loss: The patient reports normal hearing, and bedside tests (like finger rub) are normal. While a formal audiogram is part of a complete workup, this initial decision point assumes no subjective or obvious hearing deficit.
  • Normal Neurologic Exam: There are no focal neurologic deficits, including normal cranial nerve function, balance, and motor/sensory exams.
  • No History of Significant Head Trauma: The onset is not linked to a traumatic event.

It is critical to distinguish this group from patients with higher-risk features that do warrant imaging. This guidance does not apply if the patient presents with:

  • Unilateral Tinnitus: Tinnitus in only one ear raises suspicion for retrocochlear pathology, such as a vestibular schwannoma, and typically requires an MRI.
  • Pulsatile Tinnitus: A pulsing or whooshing sound synchronized with the heartbeat suggests a vascular etiology and requires a different imaging workup, often starting with MRA or CTA.
  • Associated Hearing Loss or Neurologic Deficits: The presence of hearing loss, vertigo, facial weakness, or other focal deficits immediately moves the patient into a higher-risk category requiring imaging.

What Diagnoses Are You Working Up in This Scenario?

In the absence of red-flag symptoms, the differential diagnosis for bilateral nonpulsatile tinnitus shifts away from structural or vascular abnormalities and toward more common, systemic, or otologic causes that imaging cannot detect. The clinical goal is not to find a discrete lesion but to identify and manage underlying contributors.

Presbycusis: The most common cause is age-related hearing loss. Even if a patient does not subjectively report hearing loss, early, high-frequency deficits are common and can manifest as tinnitus. The brain may generate a phantom sound to compensate for the lack of external auditory input at those frequencies. Imaging in this context is unrevealing.

Noise-Induced Hearing Loss: A history of significant noise exposure (occupational, recreational) can cause similar sensorineural damage, leading to tinnitus. Like presbycusis, this is a diagnosis based on history and audiometry, not imaging findings.

Ototoxic Medications: A wide range of common medications can cause or exacerbate tinnitus, including certain antibiotics (aminoglycosides), chemotherapeutics (cisplatin), high-dose salicylates, and loop diuretics. A thorough medication review is a high-yield, no-cost diagnostic step.

Systemic Conditions: Metabolic or systemic diseases can also manifest with bilateral tinnitus. These include thyroid disorders, hyperlipidemia, vitamin B12 deficiency, and autoimmune conditions. These are investigated with laboratory testing, not radiologic studies.

Somatosensory Tinnitus: In some patients, tinnitus can be modulated by movements of the jaw, neck, or eyes, suggesting an interplay between the auditory and somatosensory systems. This is a clinical diagnosis with no corresponding imaging correlate.

Why Is Imaging Usually Not Recommended for This Presentation?

For the patient with bilateral, nonpulsatile tinnitus and a normal exam, the ACR rates virtually all imaging studies—including MRI, MRA, CT, and CTA of the head, neck, and temporal bones—as Usually not appropriate. The rationale is grounded in the principles of diagnostic yield, risk, and cost-effectiveness.

The diagnostic yield of advanced imaging in this specific, low-risk population is exceptionally low. Because the underlying causes are typically metabolic, otologic, or idiopathic, structural findings are rare. Ordering an MRI or CT is highly unlikely to identify a treatable cause for the tinnitus and has a much higher chance of revealing an incidentaloma—a clinically insignificant finding that triggers further unnecessary testing, cost, and patient anxiety.

Let’s compare the recommended approach to common alternatives:

  • MRI Head and Internal Auditory Canal: While this is the study of choice for unilateral tinnitus to rule out a vestibular schwannoma, these tumors are exceedingly rare as a cause of purely bilateral, symmetric symptoms. The low pre-test probability makes routine screening in this scenario inappropriate.
  • CTA Head and Neck: This study is essential for evaluating pulsatile tinnitus, where vascular pathologies like dural arteriovenous fistulas, carotid stenosis, or vascular loops are on the differential. For nonpulsatile tinnitus, these conditions are not a primary concern, and the study exposes the patient to unnecessary radiation (☢☢☢ 1-10 mSv) and iodinated contrast with no clear benefit.

The core principle is clinical stratification. The absence of unilateral symptoms, pulsatility, hearing loss, or neurologic deficits effectively rules out the vast majority of pathologies that imaging is designed to detect. The ACR guidance directs clinicians to avoid low-value testing and focus on a more productive clinical evaluation.

What’s Next? The Downstream Clinical Workflow

If imaging is not the answer, what is the appropriate next step for these patients? The workflow is clinical and focuses on evaluation, counseling, and management rather than anatomical diagnosis.

  • Comprehensive Audiologic Evaluation: The first and most important step is a referral to an audiologist for a complete audiogram. This test is far more sensitive than a patient’s self-report for detecting subtle, high-frequency hearing loss that is a primary driver of tinnitus. A positive finding confirms an otologic source and directs therapy.
  • Thorough Medication and History Review: Systematically review all prescription medications, over-the-counter drugs, and supplements for known ototoxicity. Inquire in detail about noise exposure history.
  • Laboratory Testing (If Indicated): If the history or review of systems suggests a potential systemic cause, targeted lab work for thyroid function (TSH), vitamin B12, or a lipid panel may be warranted.
  • Management and Counseling: If the workup is unrevealing, the focus shifts to management. This includes counseling the patient on the benign nature of the condition, discussing sound therapy (e.g., white noise machines, hearing aids with masking features), and introducing cognitive behavioral therapy (CBT) to help reduce the distress and functional impact of the tinnitus.

If the audiogram reveals significant asymmetric sensorineural hearing loss, the patient no longer fits this low-risk scenario. At that point, they should be re-evaluated, and imaging (typically an MRI) may become appropriate to investigate the cause of the asymmetry.

Pitfalls to Avoid (and When to Get Help)

The primary pitfall in this scenario is ordering unnecessary imaging, which can lead to a cascade of incidental findings and patient anxiety without benefit. Other common mistakes include:

  • Misclassifying the Tinnitus: Failing to ask specifically about pulsatility. A patient might describe a “whooshing” sound that is, in fact, pulsatile. Always ask if the sound is in sync with their heartbeat.
  • Dismissing the Symptom: While imaging is not indicated, the symptom is often very distressing to the patient. The appropriate response is not dismissal but a pivot to a non-imaging clinical workup and management strategy.
  • Overlooking Medication Side Effects: Not performing a detailed medication reconciliation, which is one of the most common and reversible causes.

Escalate or refer to otolaryngology (ENT) or audiology immediately. If at any point the patient develops new focal neurologic symptoms, vertigo, or sudden hearing loss, they should be re-evaluated urgently, as this represents a change in clinical status and requires a different diagnostic pathway.

Related ACR Topics and Tools

This article focuses on one specific clinical variant. For a comprehensive overview of all tinnitus scenarios and their corresponding imaging recommendations, from pulsatile to unilateral presentations, please consult our parent guide.

For clinicians seeking to understand adjacent scenarios or the technical details of various imaging studies, the following GigHz resources are available:

Frequently Asked Questions

If a patient is very anxious about a brain tumor, can I order an MRI just for reassurance?

While patient anxiety is an important factor, ordering a low-yield test for reassurance is generally discouraged by the ACR. The probability of finding a relevant abnormality in this specific scenario is extremely low, while the risk of discovering an unrelated incidental finding is significant. A better approach is to explain the evidence-based rationale for why a tumor is not suspected and to redirect the workup toward more likely causes, such as a formal hearing test.

What if the patient’s tinnitus is bilateral but much louder on one side?

Significant asymmetry changes the clinical picture. If the tinnitus is clearly and consistently lateralized or much more prominent in one ear, it should be managed as unilateral tinnitus. The concern for a structural retrocochlear lesion (like a vestibular schwannoma) increases, and an MRI of the internal auditory canals would then become appropriate.

Does this ‘no imaging’ recommendation apply to children?

This ACR guidance is primarily developed for adults. Tinnitus is less common in children, and its presence may warrant a more thorough investigation, often in consultation with pediatric otolaryngology. The pre-test probability of various conditions differs in pediatric populations, so this specific adult-focused guideline should be applied with caution.

If the initial clinical workup (including audiogram) is negative, is it time for imaging then?

Not necessarily. If a comprehensive audiogram is normal and a review of medications and systemic causes is unrevealing, the diagnosis is often primary or idiopathic tinnitus. The management strategy remains focused on non-imaging approaches like sound therapy and cognitive behavioral therapy. Imaging is typically reserved for cases where new, concerning symptoms develop (e.g., focal weakness, vertigo, unilateral hearing loss).

Why is pulsatile tinnitus treated so differently from nonpulsatile tinnitus?

The underlying differential diagnosis is completely different. Nonpulsatile tinnitus is typically a sensorineural phenomenon originating from the cochlea or central auditory pathways. Pulsatile tinnitus is most often a mechanical or vascular issue, where the patient is hearing blood flow. This could be due to normal but turbulent flow or a serious underlying vascular lesion like a dural arteriovenous fistula, aneurysm, or carotid dissection, all of which require urgent vascular imaging (CTA or MRA) to diagnose.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026